Gamunex-c 20 gram/200 ML vial 200ML
Ended Awarded
- Contract number
- SPE2DB26FABQ4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,737
Award facts
- Contract value 100% obligated
- $10,737.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Gamunex-C (20 gram/200 milliliter vial). This firm fixed-price delivery order, valued at $10,737.40, is set to be completed by December 1, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a non-set-aside, competitively awarded transaction under the company's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), a $1 billion prime contract that extends through December 2026 and serves as the primary pharmaceutical supply mechanism for Department of Defense medical requirements.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills a critical role in the federal medical supply chain, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates capability across a broad spectrum of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This delivery order for Gamunex-C, an immune globulin product typically used for immunodeficiency and autoimmune conditions, exemplifies the company's role in supplying specialized pharmaceutical commodities to support Defense Health Agency requirements and broader military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DB26FABQ4?
SPE2DB26FABQ4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FABQ4 worth?
The government has obligated $10,737 on SPE2DB26FABQ4.
Is contract SPE2DB26FABQ4 an order under another contract?
Yes. SPE2DB26FABQ4 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB26FABQ4 competed?
The extent of competition for SPE2DB26FABQ4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award